禽致病性大肠杆菌cOmpT单克隆抗体的研制及其识别抗原表位的鉴定

doi:10.11843/j.issn.0366-6964.2020.12.021

摘要/Abstract

摘要： 旨在制备禽致病性大肠杆菌（APEC）染色体编码外膜蛋白（cOmpT）的特异性单克隆抗体，本研究利用实验室已构建的APEC cOmpT重组表达质粒pET-28a-compT，经IPTG诱导表达后，获得以包涵体形式存在的约36 ku的重组蛋白cOmpT，利用尿素浓度梯度透析复性获得纯化蛋白cOmpT，并以此免疫BALB/c小鼠。建立间接ELISA检测方法，最适抗原包被浓度为0.625 μg·mL^-1，最适血清稀释度为1：6 400。4次免疫后取小鼠脾进行细胞融合，采用有限稀释法多轮筛选后得到3株能稳定分泌针对cOmpT蛋白的单克隆抗体，分别命名为1G8、2C3和2G3，均为IgG2b亚类。3株杂交瘤细胞上清ELISA抗体效价分别为1：200、1：3 200和1：3 200。Western blot结果显示，3株单抗均能与cOmpT发生特异性反应，而不与其他受检菌发生交叉反应。运用原核表达系统对compT基因进行截短表达，对单克隆抗体针对的cOmpT抗原表位进行鉴定，结果显示单抗1G8、2C3和2G3识别的抗原表位分别是⁸³DQDWMDS⁸⁹、⁹⁰SNPGTW⁹⁵和¹⁹⁷TFKYSGW²⁰³。本研究成功制备了3株抗cOmpT蛋白的单克隆抗体，并对其识别的抗原表位进行了鉴定，为cOmpT蛋白功能研究和APEC新型表位疫苗研发奠定了基础。

关键词: 禽致病性大肠杆菌, cOmpT, 单克隆抗体, 抗原表位

Abstract: To development monoclonal antibodies against cOmpT of avian pathogenic Escherichia coli (APEC), the recombinant cOmpT of APEC origin expression plasmid pET-28a-compT was employed, and cOmpT protein with a molecular weight about 36 kD in the form of inclusion bodies was obtained after induction with IPTG, and then renatured by urea gradient dialysis. BALB/c mice were immunized with the purified cOmpT. An indirect enzyme-linked immunosorbent assay (iELISA) was developed, the optimal coating concentration of the antigen was 0.625 μg·mL^-1 and the optimal serum dilution was 1:6 400. After the fourth immunization, the spleen of immunized mice was collected for cell fusion, three monoclonal hybridomas that can secrete antibody specific to cOmpT were obtained after multiple screenings, named 1G8, 2C3 and 2G3 respectively. And all of their immunoglobulin subclasses were IgG2b. The titers of monoclonal antibodies in the cell culture supernatant were 1:200, 1:3 200 and 1:3 200 determined by iELISA, respectively. All three monoclonal antibodies were confirmed to react with cOmpT in Western blot, without cross reaction with other tested bacteria. The antigenic epitopes recognized by the three monoclonal antibodies were identified by using a series of E. coli strains harboring expression plasmids recombined with truncated fragments from compT gene. The results revealed that the antigenic epitope required for reactivity with the 1G8 was ⁸³DQDWMDS⁸⁹, and ⁹⁰SNPGTW⁹⁵, ¹⁹⁷TFKYSGW²⁰³were recognized by 2C3 and 2G3, respectively. In this study, three monoclonal antibodies against cOmpT were successfully developed and the antigenic epitopes recognized by the antibodies were identified. The cOmpT specific monoclonal antibodies obtained in this study are potentially useful tools for both the functional study of cOmpT and the development of APEC epitope vaccines.

Key words: APEC, cOmpT, monoclonal antibody, antigenic epitope

中图分类号:

S852.612

薛菲, 杨梓纯, 许炎辉, 王娅玲, 喻婷, 樊毛迪, 刘娟华, 高崧, 刘秀梵. 禽致病性大肠杆菌cOmpT单克隆抗体的研制及其识别抗原表位的鉴定[J]. 畜牧兽医学报, 2020, 51(12): 3122-3132.

XUE Fei, YANG Zichun, XU Yanhui, WANG Yaling, YU Ting, FAN Maodi, LIU Juanhua, GAO Song, LIU Xiufan. Development of Monoclonal Antibodies against the cOmpT Protein of Avian Pathogenic Escherichia coli and Identification of Epitopes Recognized by Monoclonal Antibodies[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(12): 3122-3132.

参考文献 30

[1]	CROXEN M A, FINLAY B B. Molecular mechanisms of Escherichia coli pathogenicity[J]. Nat Rev Microbiol, 2010, 8(1):26-38.
[2]	WANG X R, WEI L Y, WANG B, et al. Complete genome sequence and characterization of avian pathogenic Escherichia coli field isolate ACN001[J]. Stand Genomic Sci, 2016, 11:13.
[3]	LANDMAN W J M, VAN ECK J H H. The incidence and economic impact of the Escherichia coli peritonitis syndrome in Dutch poultry farming[J]. Avian Pathol, 2015, 44(5):370-378.
[4]	CORDONI G, WOODWARD M J, WU H H, et al. Comparative genomics of European avian pathogenic E. Coli (APEC)[J]. BMC Genomics, 2016, 17(1):960.
[5]	MITCHELL N M, JOHNSON J R, JOHNSTON B, et al. Zoonotic potential of Escherichia coli isolates from retail chicken meat products and eggs[J]. Appl Environ Microbiol, 2015, 81(3):1177-1187.
[6]	ZHU Z M, DONG C F, WENG S P, et al. Identification of outer membrane protein TolC as the major adhesin and potential vaccine candidate for Vibrio harveyi in hybrid grouper, Epinephelus fuscoguttatus (♀)×E. lanceolatus (♂)[J]. Fish Shellfish Immunol, 2019, 86:143-151.
[7]	VAN GOOR A, STROMBERG Z R, MELLATA M. A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli[J]. PLoS One, 2017, 12(8):e0183929.
[8]	陈娟. 禽致病性大肠杆菌E058株compT、pompT基因突变株的构建及其致病性评价[D]. 扬州:扬州大学, 2016.CHEN J. Construction of compT, pompT knockout mutants of in avian pathogenic E. coli E058 and evaluation their pathogenicity[D]. Yangzhou:Yangzhou University, 2016. (in Chinese)
[9]	GYLES C L. Antimicrobial resistance in selected bacteria from poultry[J]. Anim Health Res Rev, 2008, 9(2):149-158.
[10]	WOOLEY R E, SPEARS K R, BROWN J, et al. Relationship of complement resistance and selected virulence factors in pathogenic avian Escherichia coli[J]. Avian Dis, 1992, 36(3):679-684.
[11]	高崧, 吴晓东, 张扬, 等. 禽大肠杆菌外膜蛋白、脂多糖疫苗的免疫保护试验[J]. 中国兽医学报, 2002, 22(5):457-459.GAO S, WU X D, ZHANG Y, et al. Immunogenicity of oil-emusified outer membrane proteins and lipopolysaccharides of Escherichia coli against homologous challenge[J]. Chinese Journal of Veterinary Science, 2002, 22(5):457-459. (in Chinese)
[12]	俱雄, 陈春琳, 刘祥, 等. 重组大肠埃希菌外膜蛋白C的表达、纯化及多克隆抗体制备[J]. 陕西理工学院学报:自然科学版, 2015, 31(3):52-57.JU X, CHEN C L, LIU X, et al. Expression, purification and polyclonal antibody preparation of recombinant E. coli outer membrane protein OmpC[J]. Journal of Shaanxi University of Technology:Natural Science Edition, 2015, 31(3):52-57. (in Chinese)
[13]	赵冬. 猪圆环病毒3型回顾性调查与cap蛋白单克隆抗体的研制[D]. 扬州:扬州大学, 2018.ZHAO D. Retrospective survey of porcine circovirus type 3 in Jiangsu province and development of monoclonal antibodies against cap proteins of PCV3[D]. Yangzhou:Yangzhou University, 2018. (in Chinese)
[14]	JOHNSON J R, RUSSO T A. Extraintestinal pathogenic Escherichia coli:"The other bad E.coli"[J]. J Lab Clin Med, 2002, 139(3):155-162.
[15]	STOKHOLM N M, PERMIN A, BISGAARD M, et al. Causes of mortality in commercial organic layers in Denmark[J]. Avian Dis, 2010, 54(4):1241-1250.
[16]	TIVENDALE K A, LOGUE C M, KARIYAWASAM S, et al. Avian-pathogenic Escherichia coli strains are similar to neonatal meningitis E. coli strains and are able to cause meningitis in the rat model of human disease[J]. Infect Immun, 2010, 78(8):3412-3419.
[17]	EWERS C, LI G, WILKING H, et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli:how closely related are they?[J]. Int J Med Microbiol, 2007, 297(3):163-176.
[18]	佟春玉, 李润婷, 呼瑞, 等. 重组大肠杆菌外膜蛋白OmpT对小鼠免疫保护作用的研究[J]. 中国预防兽医学报, 2013, 35(8):658-662.TONG C Y, LI R T, HU R, et al. Evaluation of the imunoprotection induced by recombinant OmpT protein of Escherichia coli in mice[J]. Chinese Journal of Preventive Veterinary Medicine, 2013, 35(8):658-662. (in Chinese)
[19]	赵铁. 尿路致病性大肠埃希菌外膜蛋白T致病相关的功能研究[D]. 广州:南方医科大学, 2012.ZHAO T. Function of the pathopoiesia about outer membrane protein T of Uropathogenic Escherichia coli[D]. Guangzhou:Southern Medical University, 2012. (in Chinese)
[20]	孙娟, 王愉涵, 刘艳, 等. 抗原表位鉴定方法的研究进展[J]. 国外医学(医学地理分册), 2017, 38(3):291-295.SUN J, WANG Y H, LIU Y, et al. Research advances in the identification methods of antigen epitope[J]. Foreign Medical Sciences (Section of Medgeography), 2017, 38(3):291-295. (in Chinese)
[21]	俱雄. 大肠埃希菌外膜蛋白OmpC的原核表达及免疫原性分析[D]. 汉中:陕西理工学院, 2016.JU X. Prokaryotic expression and immunogenicity analysis of E. coli outer membrane protein OmpC[D]. Hanzhong:Shaanxi University of Technology, 2016. (in Chinese)
[22]	俱雄, 党亚锋, 刘祥, 等. 大肠杆菌外膜蛋白OmpC的生物信息学分析及表位多肽疫苗的重组预测[J]. 河南农业大学学报, 2017, 51(1):94-100.JU X, DANG Y F, LIU X, et al. Bioinformatic analysis of E. coli OmpC and recombinant prediction of epitope peptide vaccine[J]. Journal of Henan Agricultural University, 2017, 51(1):94-100. (in Chinese)
[23]	SKOWICKI M, LIPIŃSKI T. The development of methods for obtaining monoclonal antibody-producing cells[J]. Postepy Hig Med Dosw (Online), 2016, 70:367-379.
[24]	LITTLE M, KIPRIYANOV S M, LE GALL F, et al. Of mice and men:hybridoma and recombinant antibodies[J]. Immunol Today, 2000, 21(8):364-370.
[25]	GAO Y L, HUANG X X, ZHU Y B, et al. A brief review of monoclonal antibody technology and its representative applications in immunoassays[J]. J Immunoassay Immunochem, 2018, 39(4):351-364.
[26]	闫慧丽, 席俊, 高学梅, 等. 抗Gly m Bd 28K单克隆抗体的制备及其免疫学特性[J]. 浙江农业学报, 2016, 28(5):748-752.YAN H L, XI J, GAO X M, et al. Preparation of monoclonal antibodies against Gly m Bd 28K and identification of their immunological properties[J]. Acta Agriculturae Zhejiangensis, 2016, 28(5):748-752. (in Chinese)
[27]	曹智刚, 易立, 程悦宁, 等. 抗犬瘟热病毒核蛋白单克隆抗体的制备及其线性抗原表位鉴定[J]. 中国预防兽医学报, 2017, 39(7):578-582.CAO Z G, YI L, CHEN Y N, et al. Preparation and identification of linear epitope of monoclonal antibodies against Canine distemper virus N protein[J]. Chinese Journal of Preventive Veterinary Medicine, 2017, 39(7):578-582. (in Chinese)
[28]	李健, 余传信. 表位疫苗的研究进展[J]. 中国热带医学, 2007, 7(9):1681-1684.LI J, YU C X. Advance in the research of epitope vaccine[J]. China Tropical Medicine, 2007, 7(9):1681-1684. (in Chinese)
[29]	MOISE L, MCMURRY J, RIVERA D S, et al. Progress towards a genome-derived, epitope-driven vaccine for latent TB infection[J]. Med Health R I, 2007, 90(10):301-303.
[30]	王新军, 张兆松. 表位疫苗:疫苗研制新策略[J]. 中国寄生虫学与寄生虫病杂志, 2004, 22(6):365-367.WANG X J, ZHANG Z S. Epitope vaccine:a new strategy for vaccine development[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2004, 22(6):365-367. (in Chinese)